Misoprostol Reduces Gastroduodenal Injury From One Week of Aspirin: An Endoscopic Study

Gastroenterology

Volumn 96, Issue 2, 1989, Pages 656-661

  Jiranek, G C ^a,b   Kimmey, M B ^a,b   Saunders, D R ^a,b   Willson, R A ^a,b   Shanahan, W ^a,b   Silverstein, F E ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; MISOPROSTOL;

ADULT; CELL PROTECTION; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DUODENUM ULCER; ENDOSCOPY; HUMAN; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

ADOLESCENT; ADULT; ALPROSTADIL; ANTI-ULCER AGENTS; ASPIRIN; CLINICAL TRIALS; DOUBLE-BLIND METHOD; DUODENAL ULCER; GASTROSCOPY; HUMAN; MALE; MISOPROSTOL; RANDOM ALLOCATION; STOMACH ULCER; SUPPORT, NON-U.S. GOV'T;

EID: 0024591879     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0016-5085(89)80062-9     Document Type: Article

References (29)

1. Effect of aspirin on the human stomach in normals: endoscopic comparison of damage produced one hour, 24 hours, and 2 weeks after administration
2. Endoscopic studies of gastric and duodenal injury after the use of ibuprofen, aspirin and other non-steroidal anti-inflammatory agents
3. Subepithelial hemorrhages and erosions of human stomach
4. Aspirin and gastric ulcer
5. Aspirin use in patients with major upper gastrointestinal bleeding and peptic ulcer disease: a' report from the Boston Collaborative Drug Surveillance Program
6. Incidence of gastric lesions in patients with rheumatic disease on chronic aspirin therapy
7. Non-steroidal anti-inflammatory drugs and life threatening complications of peptic ulceration
8. Non-steroidal antiinflammatory drugs and bleeding peptic ulcer
9. Non-steroidal anti-inflammatory drugs and peptic ulcer perforation
10. Rising frequency of ulcer perforation in elderly people in the United Kingdom
11. Prostaglandins and the gastrointestinal mucosa: are they important in its function, disease, or treatment?
12. A multicenter international controlled comparison of two dosage regimes of misoprostol and cimetidine in the treatment of duodenal ulcer in out-patients
13. 1
14. Misoprostol in the treatment of duodenal ulcer: a multicenter double-blind placebo-controlled study
15. 1 analog, in the treatment of duodenal ulcers: a multicenter double-blind study
16. A multicenter international controlled comparison of two dosage regimens of misoprostol with cimetidine in treatment of gastric ulcer in outpatients
17. Efficacy of misoprostol (twice daily dosage) in acute healing of duodenal ulcer: a multicenter double-blind controlled trial
18. Selective inhibition of prostaglandin production in inflammatory exudates and gastric mucosa
19. NSAIDs-should every prescription carry a government health warning?
20. Prevention of acute aspirin-induced gastric mucosal injury by 15-R-15methyl prostaglandin Ez: an endoscopic study
21. Gastric protection by misoprostol against 1300 mg aspirin: an endoscopic study
22. Double-blind, placebo- controlled endoscopic comparison of the mucosal protective effects of misoprostol versus cimetidine on tolmetininduced mucosal injury to the stomach and duodenum
23. Inhibition of nocturnal gastric secretion in normal human volunteers by misoprostol: a synthetic prostaglandin E1 methyl ester analog
24. Effects of misoprostol on gastric acid and mucus secretion in man
25. Human duodenal mucosal bicarbonate secretion: evidence for basal secretion by hydrochloric acid and a synthetic prostaglandin E1 analogue
26. Misoprostol-induced changes in gastric mucosal hemodynamics: a double-blind parallel study in human volunteers
27. 2 in the gastrointestinal tract during indomethacin treatment of rheumatoid diseases
28. Gastric adaption occurs with aspirin administration in man